Why GLP-1 Drugs Are A Big Deal for FMCG Companies and the Sugar Industry
Why GLP-1 Drugs Are A Big Deal for FMCG Companies and the Sugar Industry
GLP-1 drugs like Ozempic and Wegovy are going mainstream. One in eight Americans have now tried them. Yet there’s surprisingly little discussion about them in the sugar and food/beverage industries. We think their usage should be taken more seriously and could re-shape food consumption and energy production.
Join us for this webinar where we look into this topic further.
CZ Advise
Join us for this webinar where we look into this topic further.
CZ Advise